Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00453882 · ClinicalTrials.gov registry record · NA

Uretal Flow Assessment During Gynecological Procedures

A NA study, sponsored by Ethicon.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT00453882 is a NA study that has completed, run by Ethicon. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00453882, a NA study, has completed, sponsored by Ethicon.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

The objective is to evaluate the feasibility of using color Doppler ultrasound in ureteral flow assessment after uterine artery occlusion during a conservative gynecological procedure.

Interventions

  • DEVICE flostat (TM) System

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2006-11
Est. Completion 2007-04
Phase NA

Sponsor

Ethicon

38 total trials

What the Registry Record Tells You About NCT00453882

The ClinicalTrials.gov registry entry for NCT00453882 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which flostat (TM) System is the first listed.

NCT00453882 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00453882 about?

NCT00453882 is a clinical study titled "Uretal Flow Assessment During Gynecological Procedures". The objective is to evaluate the feasibility of using color Doppler ultrasound in ureteral flow assessment after uterine artery occlusion during a conservative gynecological procedure.

What is the current status of trial NCT00453882?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2006-11. Estimated completion is 2007-04.

What interventions are being tested in trial NCT00453882?

The interventions under investigation include: flostat (TM) System (DEVICE).

Who is sponsoring clinical trial NCT00453882?

This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.